NEW_CURA-LEAF_1170x120_OCT

EpiPen Jr

Mylan, DOJ finalize settlement on EpiPen

Mylan, DOJ finalize settlement on EpiPen

PITTSBURGH — Mylan Inc. and Mylan Specialty L.P. have entered an agreement with the U.S. Department of Justice finalizing the $465 million Medicaid drug rebate settlement last fall. Mylan said late Thursday that the settlement, announced Oct. 7, resolves claims over the classification of the EpiPen and EpiPen Jr epinephrine auto-injectors in the Medicaid Drug